The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma
Abstract
Three hundred forty-nine patients with asthma previously treated with medium doses of inhaled corticosteroids during a 2-wk, single-blind, run-in period were randomized to treatment with salmeterol 50 microg combined with fluticasone propionate (FP) 250 microg, salmeterol 50 microg, FP 250 microg, or placebo, each given twice daily through a Diskus device for 12 wk. Mean change in FEV(1) at endpoint was significantly (p </= 0.001) greater with the salmeterol/FP combination product (0.48 L) than with placebo (-0.11 L), salmeterol (0.05 L), or FP (0.25 L). The combination product significantly increased the area under the 12-h serial FEV(1) curve relative to baseline over that with placebo, salmeterol, or FP at Day 1, Week 1, and Week 12 (p </= 0.025). Patients in the combination-product group had a significantly greater probability of remaining in the study without being withdrawn because of worsening asthma than did patients in the placebo, salmeterol, or FP groups (p </= 0.002). The combination product significantly increased (p < 0. 001) morning PEF at endpoint (53.5 L/min) as compared with placebo (-14 L/min), salmeterol (-11.6 L/min), or FP (15.2 L/min). The combination product significantly (p </= 0.011) reduced asthma symptom scores and supplemental albuterol use, and significantly increased the percentage of nights with no awakenings as compared with placebo, salmeterol, and FP (p </= 0.016). Combination treatment with salmeterol 50 microg and FP 250 microg given twice daily from the Diskus device provided better asthma control and greater improvement in pulmonary function than did the individual agents, and may simplify the management of asthma in patients who need both classes of drugs for optimal control of their disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane, G. M., Horne, R., & Chanez, P. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90260-3 · Cited by 246
Cited by
Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J. H., Pauwels, R. A., & Pedersen, S. E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-033oc · Cited by 1,594
Salpeter, S. R., Buckley, N. S., Ormiston, T. M., & Salpeter, E. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00126 · Cited by 461
Hanania, N. A., Darken, P., Horstman, D., Reisner, C., Lee, B., Davis, S., & Shah, T. (2003) · Chest · doi:10.1378/chest.124.3.834 · Cited by 327
Self-citationSoriano, J. B., Vestbo, J., Pride, N. B., Kiri, V., Maden, C., & Maier, W. C. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00301302 · Cited by 286
Kuna, P., Peters, M. J., Manjra, A. I., Jorup, C., Naya, I. P., Martínez-Jimenez, N. E., & Buhl, R. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01338.x · Cited by 274
Metadata
- Authors
- SHAPIRO, G., LUMRY, W., WOLFE, J., GIVEN, J., WHITE, M. V., WOODRING, A., BAITINGER, L., HOUSE, K., PRILLAMAN, B., & SHAH, T.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-02-01
- Volume
- 161
- Issue
- 2
- Pages
- 527-534
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2027285152
- Cited by
- 200
- References
- 1
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma. https://app.cochat.ai/papers/10.1164/ajrccm.161.2.9905091
- The paper
- SHAPIRO, G., LUMRY, W., WOLFE, J., GIVEN, J., WHITE, M. V., WOODRING, A., BAITINGER, L., HOUSE, K., PRILLAMAN, B., & SHAH, T. (2000). Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.161.2.9905091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.